unveiled SIRT2 as mediating the deacetylation of ANXA2 in HCC, thereby inhibiting mTOR activity and eliciting protective autophagy, which is responsible for donafenib resistance, a perfect example of autophagy as a survival strategy (120). The gene discussed is SIRT2; the disease is hepatocellular carcinoma.